The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
BioPharma Cold Chain Packaging-Global Market Insights and Sales Trends 2025
Synopsis
Packaging of products is the process of enclosing them for the purpose of their distribution, storage, sale, and use. Packaging also helps advertise a product in a better way and protect it from damage during transportation. Biopharma products are called as biological medical products, such as blood or blood components, vaccines, and tissues. These products require packaging to ensure their safety during transportation, to maintain sterility, and to prevent breakage or spillage and contamination.
The global BioPharma Cold Chain Packaging market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of BioPharma Cold Chain Packaging in various end use industries. The expanding demands from the Blood Components, Vaccines, Tissues and Cells, are propelling BioPharma Cold Chain Packaging market. Metal Packaging, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Glass Packaging segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for BioPharma Cold Chain Packaging, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global BioPharma Cold Chain Packaging market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global BioPharma Cold Chain Packaging market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, BioPharma Cold Chain Packaging sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of BioPharma Cold Chain Packaging covered in this report include Amcor, CCL, Clondalkin and Gerresheimer, etc.
The global BioPharma Cold Chain Packaging market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Amcor
CCL
Clondalkin
Gerresheimer
Global BioPharma Cold Chain Packaging market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global BioPharma Cold Chain Packaging market, Segment by Type:
Metal Packaging
Glass Packaging
Global BioPharma Cold Chain Packaging market, by Application
Blood Components
Vaccines
Tissues
Cells
Stem Cells
Infectious Substances
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of BioPharma Cold Chain Packaging companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Packaging of products is the process of enclosing them for the purpose of their distribution, storage, sale, and use. Packaging also helps advertise a product in a better way and protect it from damage during transportation. Biopharma products are called as biological medical products, such as blood or blood components, vaccines, and tissues. These products require packaging to ensure their safety during transportation, to maintain sterility, and to prevent breakage or spillage and contamination.
The global BioPharma Cold Chain Packaging market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of BioPharma Cold Chain Packaging in various end use industries. The expanding demands from the Blood Components, Vaccines, Tissues and Cells, are propelling BioPharma Cold Chain Packaging market. Metal Packaging, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Glass Packaging segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for BioPharma Cold Chain Packaging, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global BioPharma Cold Chain Packaging market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global BioPharma Cold Chain Packaging market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, BioPharma Cold Chain Packaging sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of BioPharma Cold Chain Packaging covered in this report include Amcor, CCL, Clondalkin and Gerresheimer, etc.
The global BioPharma Cold Chain Packaging market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Amcor
CCL
Clondalkin
Gerresheimer
Global BioPharma Cold Chain Packaging market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global BioPharma Cold Chain Packaging market, Segment by Type:
Metal Packaging
Glass Packaging
Global BioPharma Cold Chain Packaging market, by Application
Blood Components
Vaccines
Tissues
Cells
Stem Cells
Infectious Substances
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of BioPharma Cold Chain Packaging companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of BioPharma Cold Chain Packaging
1.1 BioPharma Cold Chain Packaging Market Overview
1.1.1 BioPharma Cold Chain Packaging Product Scope
1.1.2 BioPharma Cold Chain Packaging Market Status and Outlook
1.2 Global BioPharma Cold Chain Packaging Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global BioPharma Cold Chain Packaging Market Size by Region (2018-2029)
1.4 Global BioPharma Cold Chain Packaging Historic Market Size by Region (2018-2023)
1.5 Global BioPharma Cold Chain Packaging Market Size Forecast by Region (2024-2029)
1.6 Key Regions, BioPharma Cold Chain Packaging Market Size (2018-2029)
1.6.1 North America BioPharma Cold Chain Packaging Market Size (2018-2029)
1.6.2 Europe BioPharma Cold Chain Packaging Market Size (2018-2029)
1.6.3 Asia-Pacific BioPharma Cold Chain Packaging Market Size (2018-2029)
1.6.4 Latin America BioPharma Cold Chain Packaging Market Size (2018-2029)
1.6.5 Middle East & Africa BioPharma Cold Chain Packaging Market Size (2018-2029)
2 BioPharma Cold Chain Packaging Market by Type
2.1 Introduction
2.1.1 Metal Packaging
2.1.2 Glass Packaging
2.2 Global BioPharma Cold Chain Packaging Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global BioPharma Cold Chain Packaging Historic Market Size by Type (2018-2023)
2.2.2 Global BioPharma Cold Chain Packaging Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America BioPharma Cold Chain Packaging Revenue Breakdown by Type (2018-2029)
2.3.2 Europe BioPharma Cold Chain Packaging Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific BioPharma Cold Chain Packaging Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America BioPharma Cold Chain Packaging Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa BioPharma Cold Chain Packaging Revenue Breakdown by Type (2018-2029)
3 BioPharma Cold Chain Packaging Market Overview by Application
3.1 Introduction
3.1.1 Blood Components
3.1.2 Vaccines
3.1.3 Tissues
3.1.4 Cells
3.1.5 Stem Cells
3.1.6 Infectious Substances
3.2 Global BioPharma Cold Chain Packaging Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global BioPharma Cold Chain Packaging Historic Market Size by Application (2018-2023)
3.2.2 Global BioPharma Cold Chain Packaging Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America BioPharma Cold Chain Packaging Revenue Breakdown by Application (2018-2029)
3.3.2 Europe BioPharma Cold Chain Packaging Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific BioPharma Cold Chain Packaging Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America BioPharma Cold Chain Packaging Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa BioPharma Cold Chain Packaging Revenue Breakdown by Application (2018-2029)
4 BioPharma Cold Chain Packaging Competition Analysis by Players
4.1 Global BioPharma Cold Chain Packaging Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in BioPharma Cold Chain Packaging as of 2022)
4.3 Date of Key Players Enter into BioPharma Cold Chain Packaging Market
4.4 Global Top Players BioPharma Cold Chain Packaging Headquarters and Area Served
4.5 Key Players BioPharma Cold Chain Packaging Product Solution and Service
4.6 Competitive Status
4.6.1 BioPharma Cold Chain Packaging Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Amcor
5.1.1 Amcor Profile
5.1.2 Amcor Main Business
5.1.3 Amcor BioPharma Cold Chain Packaging Products, Services and Solutions
5.1.4 Amcor BioPharma Cold Chain Packaging Revenue (US$ Million) & (2018-2023)
5.1.5 Amcor Recent Developments
5.2 CCL
5.2.1 CCL Profile
5.2.2 CCL Main Business
5.2.3 CCL BioPharma Cold Chain Packaging Products, Services and Solutions
5.2.4 CCL BioPharma Cold Chain Packaging Revenue (US$ Million) & (2018-2023)
5.2.5 CCL Recent Developments
5.3 Clondalkin
5.3.1 Clondalkin Profile
5.3.2 Clondalkin Main Business
5.3.3 Clondalkin BioPharma Cold Chain Packaging Products, Services and Solutions
5.3.4 Clondalkin BioPharma Cold Chain Packaging Revenue (US$ Million) & (2018-2023)
5.3.5 Gerresheimer Recent Developments
5.4 Gerresheimer
5.4.1 Gerresheimer Profile
5.4.2 Gerresheimer Main Business
5.4.3 Gerresheimer BioPharma Cold Chain Packaging Products, Services and Solutions
5.4.4 Gerresheimer BioPharma Cold Chain Packaging Revenue (US$ Million) & (2018-2023)
5.4.5 Gerresheimer Recent Developments
6 North America
6.1 North America BioPharma Cold Chain Packaging Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe BioPharma Cold Chain Packaging Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific BioPharma Cold Chain Packaging Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America BioPharma Cold Chain Packaging Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa BioPharma Cold Chain Packaging Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 BioPharma Cold Chain Packaging Market Dynamics
11.1 BioPharma Cold Chain Packaging Industry Trends
11.2 BioPharma Cold Chain Packaging Market Drivers
11.3 BioPharma Cold Chain Packaging Market Challenges
11.4 BioPharma Cold Chain Packaging Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
